AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 41 filers reported holding AQUINOX PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $430,000 | – | 25,738 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 877,753 | $14,492,000 | 5.61% |
| RA Capital Management | 2,191,977 | $36,190,000 | 5.13% |
| Opaleye Management Inc. | 310,000 | $5,118,000 | 3.02% |
| EMORY UNIVERSITY | 143,691 | $2,372,000 | 2.34% |
| Baker Brothers Advisors | 10,536,092 | $173,951,000 | 1.70% |
| Ghost Tree Capital, LLC | 225,000 | $3,715,000 | 0.89% |
| Cormorant Asset Management, LP | 151,838 | $2,507,000 | 0.34% |
| Eventide Asset Management | 175,000 | $2,889,000 | 0.19% |
| JGP Global Gestao de Recursos Ltda. | 11,380 | $188,000 | 0.10% |
| Virtus ETF Advisers LLC | 16,347 | $270,000 | 0.08% |